Dosimetric study of 3DCRT and IMRT for whole-brain radiotherapy with simultaneous integrated boost to brain metastases

倪玲琴,应申鹏,刘艳梅,王勇,吴朝霞,David Huang
2017-01-01
Abstract:Objective To investigate the dosimetric differences of 3DCRT and IMRT for whole-brain radiotherapy with simultaneous integrated boost to brain metastases.Methods Forty one previously treated cancer patients with brain metastases were replanned using 3DCRT and IMRT,respectively.The prescription dose was 3000cGy/10 fractions for whole brain (PTV),and 4000cGy/10 fractions for individual brain metastases (PGTV) simultaneously.The conformation number (CN) and homogeneity index (HI) of the target,and the monitor units (MU) were compared.Results Both treatment plans met the clinical requirements.The target dose conformity of IMRT was better than that of 3DCRT (P<0.05).The homogeneity index and monitor units of 3DCRT were better than those of IMRT (P<0.05).For the cases with 2 metastases which were not on the same slice,and 3 or 4 metastases which were on the same slice,there was no statistical difference in the target dose conformity between 3DCRT and IMRT(P >0.05),while the homogeneity index and monitor units of 3DCRT was better than IMRT(P<0.05).For the cases with 3 metastases which were not on the same slice,there was no statistical difference in the target dose conformity and homogeneity index between 3DCRT and IMRT (P >0.05),while the monitor units of 3DCRT was better than that of IMRT (P<0.05).Conclusion Two types of plans can satisfy the clinical requirements.Under some special conditions,such as 2 or 3 metastases which were not on the same slice,or 3 or 4 metastases which were on the same slice,the 3DCRT plan is better.
What problem does this paper attempt to address?